RT Journal Article
SR Electronic
T1 An increase in aspartate aminotransferase levels can predict worsening disease severity in Japanese patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.23.24306214
DO 10.1101/2024.04.23.24306214
A1 Matsumoto, Kengo
A1 Nishida, Tsutomu
A1 Okabe, Satoru
A1 Sakamoto, Naohiro
A1 Fujii, Yoshifumi
A1 Osugi, Naoto
A1 Sugimoto, Aya
A1 Nakamatsu, Dai
A1 Yamamoto, Masashi
A1 Fukui, Koji
A1 Morimura, Osamu
A1 Abe, Kinya
A1 Okauchi, Yukiyoshi
A1 Iwahashi, Hiromi
A1 Inada, Masami
YR 2024
UL http://medrxiv.org/content/early/2024/04/24/2024.04.23.24306214.abstract
AB Background The prognostic significance of liver dysfunction in coronavirus disease 2019 (COVID-19) patients remains unclear. This study aimed to investigate the association between liver function test results and severe disease progression in COVID-19 patients.Methods We conducted a retrospective study that included consecutive Japanese COVID-19 patients between February 2020 and May 2021. We identified the predictive variables for severe disease progression by utilizing established factors and multivariate logistic analysis. The Kaplan‒Meier method was used to estimate severe disease-free survival. Furthermore, we evaluated the hazard ratios (HRs) among three aspartate aminotransferase (AST) grades using Cox regression analysis: grade 1, AST < 30 U/L; grade 2, 30 U/L≤ AST < 60 U/L; and grade 3, AST >60 U/L.Results After exclusion, 604 symptomatic COVID-19 patients were enrolled during the study period, and 141 (23.3%) of them developed severe disease at a median of 2 days postadmission. The median hospital stay was 10 days, and 43 patients (7.1%) died during hospitalization. Multivariate regression analysis of the fourteen significant variables revealed that hypertension, decreased lymphocyte count, and elevated LDH, CRP, and AST levels (grade 2 and grade 3 relative to grade 1) were significant predictive variables. Severe disease-free survival times were significantly separated according to AST grade severity (HR: grade 2 to grade 1: 4.07 (95% CI: 2.06-8.03); HR: grade 3 to grade 1: 7.66 (95% CI: 3.89-15.1)).Conclusion AST levels at admission were an independent risk factor for severe disease in hospitalized Japanese patients with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical Trial2021-10-3Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in accordance with the Declaration of Helsinki, and the institutional review board of Toyonaka Municipal Hospital approved this study (2021-10-3).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author Kengo Matsumoto. The data are not publicly available due to restrictions (e.g., they contain information that could compromise the privacy of the research participants).